Novo Nordisk trades flat near 52-week low as growth slows
Novo Nordisk shares slipped 0.07% to $41.60 on Nov. 16, holding near the bottom of a 52-week range that stretches from $224.25 to $409.95. The stock has shed roughly 82% from its high as revenue growth decelerated to 5.6% year over year and EPS growth slowed to 4.9%. Net margin remains strong at 35.4%. The Alpha Score of 42.6 reflects weak momentum at 24.4, offset by quality at 70.3 and value at 51.9. The P/E of 10.34 is well below the sector median. Investors will watch for any update on pipeline catalysts or demand trends for GLP-1 products in the coming weeks.